Terms: = Kidney tumors AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
26 results:
1. PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.
Chang Q; Sun J; Zhao S; Li L; Zhang N; Yan L; Fan Y; Liu J
Aging (Albany NY); 2023 Nov; 15(23):13753-13775. PubMed ID: 38048211
[TBL] [Abstract] [Full Text] [Related]
2. Radiomics Model for Predicting foxp3 Expression Level and Survival in Clear Cell Renal Carcinoma.
Wang J; Huang Z; Zhou J
Acad Radiol; 2024 Apr; 31(4):1447-1459. PubMed ID: 37940428
[TBL] [Abstract] [Full Text] [Related]
3. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
[TBL] [Abstract] [Full Text] [Related]
4. Investigating the Role of
Xu S; Hu X; Chong Y; Zhu G
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569676
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of CD73/adenosine 2A receptor (A2AR) in renal cell carcinoma and immune microenvironmental status with sarcomatoid changes and rhabdoid features.
Takamatsu D; Kiyozawa D; Kohashi K; Kinoshita F; Toda Y; Ishihara S; Eto M; Oda Y
Pathol Res Pract; 2023 Apr; 244():154423. PubMed ID: 36989848
[TBL] [Abstract] [Full Text] [Related]
6. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
Zhou S; Lu Y; Chen Y; Gan W
Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
[TBL] [Abstract] [Full Text] [Related]
7. Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma.
Deng Y; Guo K; Tang Z; Feng Y; Cai S; Ye J; Xi Y; Li J; Liu R; Cai C; Tan Z; Zhang Y; Han Z; Zeng G; Zhong W
Front Immunol; 2022; 13():1046790. PubMed ID: 36505457
[TBL] [Abstract] [Full Text] [Related]
8. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract] [Full Text] [Related]
10. Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma.
Murakami T; Tanaka N; Takamatsu K; Hakozaki K; Fukumoto K; Masuda T; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Sawada K; Imamura T; Mizuno R; Oya M
Cancer Immunol Immunother; 2021 Oct; 70(10):3001-3013. PubMed ID: 34259900
[TBL] [Abstract] [Full Text] [Related]
11. Non-invasive Detection of Immunotherapy-Induced Adverse Events.
Ferreira CA; Heidari P; Ataeinia B; Sinevici N; Sise ME; Colvin RB; Wehrenberg-Klee E; Mahmood U
Clin Cancer Res; 2021 Oct; 27(19):5353-5364. PubMed ID: 34253581
[TBL] [Abstract] [Full Text] [Related]
12. Identification of an immune overdrive high-risk subpopulation with aberrant expression of foxp3 and CTLA4 in colorectal cancer.
Cui K; Yao S; Zhang H; Zhou M; Liu B; Cao Y; Fei B; Huang S; Huang Z
Oncogene; 2021 Mar; 40(11):2130-2145. PubMed ID: 33627780
[TBL] [Abstract] [Full Text] [Related]
13. Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer.
Kim SW; Roh J; Lee HS; Ryu MH; Park YS; Park CS
Gastric Cancer; 2021 Mar; 24(2):327-340. PubMed ID: 32924090
[TBL] [Abstract] [Full Text] [Related]
14. Immune checkpoint status and tumor microenvironment in vulvar squamous cell carcinoma.
Cocks M; Chaux A; Jenson EG; Miller JA; Rodriguez Pena MDC; Tregnago AC; Taheri D; Eich ML; Sharma R; Vang R; Netto GJ
Virchows Arch; 2020 Jul; 477(1):93-102. PubMed ID: 31993774
[TBL] [Abstract] [Full Text] [Related]
15. PD-L1 expression and infiltration by CD4
Lee HJ; Shin DH; Lee YJ; Lee SJ; Hwang CS; Kim A; Park WY; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Park SW
Histopathology; 2020 Apr; 76(5):714-721. PubMed ID: 31841221
[TBL] [Abstract] [Full Text] [Related]
16. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
[TBL] [Abstract] [Full Text] [Related]
17. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
18. Expression and prognostic role of MEKK3 and pERK in patients with renal clear cell carcinoma.
Chen Q; Lu HS; Gan MF; Chen LX; He K; Fan GM; Cao XQ
Asian Pac J Cancer Prev; 2015; 16(6):2495-9. PubMed ID: 25824786
[TBL] [Abstract] [Full Text] [Related]
19. Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: could it be a general phenomenon?
Clavijo-Salomon MA; Ramos RN; Crippa A; Pizzo CR; Bergami-Santos PC; Barbuto JA
Cancer Immunol Immunother; 2015 Feb; 64(2):161-71. PubMed ID: 25314913
[TBL] [Abstract] [Full Text] [Related]
20. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.
Gerlinger M; Quezada SA; Peggs KS; Furness AJ; Fisher R; Marafioti T; Shende VH; McGranahan N; Rowan AJ; Hazell S; Hamm D; Robins HS; Pickering L; Gore M; Nicol DL; Larkin J; Swanton C
J Pathol; 2013 Dec; 231(4):424-32. PubMed ID: 24122851
[TBL] [Abstract] [Full Text] [Related]
[Next]
